Dr Lisa Devine discusses recently updated advice regarding the risk of drug-induced liver injury with fezolinetant and new recommendations on monitoring of liver function before and during treatment.
Create an account to add page annotations
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page